Key Events This Week
3 Aug: Stock opens at Rs.5,009.70, up 0.29% amid cautious technical outlook
4 Aug: Q1 FY27 results reveal strong revenue growth but margin pressure; technical momentum shifts mildly bearish
5 Aug: Valuation metrics improve, signalling renewed price attractiveness despite Mojo Grade downgrade
7 Aug: Week closes at Rs.5,251.45, up 5.13% for the week, outperforming Sensex

Dr Agarwals Eye Hospital Ltd: Valuation Shifts Signal Renewed Price Attractiveness
2026-08-05 08:02:11Dr Agarwals Eye Hospital Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive valuation grade. This change is underpinned by a recalibration of key metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV), positioning the hospital chain favourably against its peers in the hospital sector. Despite a recent downgrade in its overall Mojo Grade to Sell, the valuation appeal of the stock has improved, offering investors a nuanced perspective on its price attractiveness amid broader market dynamics.
Read full news articleAre Dr Agarwals Eye Hospital Ltd latest results good or bad?
2026-08-04 19:20:08Dr Agarwal's Eye Hospital Ltd has reported its financial results for Q1 FY27, showcasing a robust revenue performance with net sales reaching ₹142.97 crores, reflecting a year-on-year growth of 22.28%. This marks the eighth consecutive quarter of revenue growth, indicating a consistent upward trajectory driven by strong patient footfall and successful capacity expansion initiatives. The standalone net profit for the quarter was ₹23.38 crores, which represents a year-on-year increase of 35.46%. However, the operating margin has contracted by 148 basis points year-on-year to 30.26%, despite a sequential improvement from the previous quarter. This contraction suggests that while revenue is growing, the company is facing rising costs, particularly in employee expenses, which increased significantly year-on-year. The net profit margin also improved to 16.35% from 14.76% in the same quarter last year, primarily...
Read full news article
Dr Agarwal's Eye Hospital Q1 FY27: Strong Revenue Growth Masks Margin Pressure and Technical Weakness
2026-08-04 09:48:30Dr Agarwal's Eye Hospital Ltd., a leading chain of eye hospitals with predominant presence in Tamil Nadu, reported robust topline expansion in Q1 FY27 with net sales surging 22.28% year-on-year to ₹142.97 crores. Net profit stood at ₹23.38 crores, marking a 35.49% increase from ₹17.26 crores in Q1 FY26, whilst sequential growth of 43.97% from Q4 FY26's ₹16.24 crores demonstrated strong operational momentum. The stock, currently trading at ₹5,109.05 with a market capitalisation of ₹2,503 crores, has gained 1.98% in post-result trading, though technical indicators signal underlying weakness with a mildly bearish trend.
Read full news article
Dr Agarwals Eye Hospital Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-08-04 08:06:31Dr Agarwals Eye Hospital Ltd has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish stance, reflecting a nuanced change in investor sentiment. Despite a modest day gain of 0.29%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical parameter changes and their implications for the hospital sector small-cap stock.
Read full news articleDr Agarwals Eye Hospital Ltd Falls 0.47%: 3 Key Technical Signals Driving the Week
2026-08-01 16:03:38
Key Events This Week
27 Jul: Stock opens at Rs.5,041.05, Sensex gains 1.05%
30 Jul: Death Cross formation signals potential bearish trend
31 Jul: Downgrade to Sell rating amid bearish technicals
31 Jul: Week closes at Rs.4,995.00, down 0.47%

Dr Agarwals Eye Hospital Ltd Downgraded to Sell Amid Bearish Technicals and Valuation Concerns
2026-07-31 08:08:35Dr Agarwals Eye Hospital Ltd has seen its investment rating downgraded from Hold to Sell as of 30 July 2026, driven primarily by a deterioration in technical indicators and valuation concerns despite solid financial performance and healthy long-term growth metrics. The company’s Mojo Score now stands at 40.0, reflecting a cautious stance amid mixed signals across quality, valuation, financial trends, and technical parameters.
Read full news article
Dr Agarwals Eye Hospital Ltd Faces Bearish Technical Shift Amid Mixed Momentum
2026-07-31 08:01:44Dr Agarwals Eye Hospital Ltd has experienced a notable shift in its technical parameters, moving from a mildly bullish to a bearish trend. Despite a strong long-term performance, recent momentum indicators and moving averages suggest caution for investors as the stock faces downward pressure amid sideways volatility.
Read full news articleBoard Meeting Outcome for Outcome Of The Board Meeting Held On August 03 2026
03-Aug-2026 | Source : BSEOutcome of the proceedings of the Board Meeting held on August 03 2026 is submitted.
Results- Unaudited Financial Results For The Quarter Ended June 30 2026
03-Aug-2026 | Source : BSEUnaudited Financial Results for the quarter ended June 30 2026 is submitted.
Announcement under Regulation 30 (LODR)-Change in Management
03-Aug-2026 | Source : BSEReappointment of cost auditors to conduct audit of the cost records of the Company for the financial year 2026-27 is submitted.
Corporate Actions
No Upcoming Board Meetings
Dr Agarwals Eye Hospital Ltd has declared 30% dividend, ex-date: 07 Nov 25
No Splits history available
No Bonus history available
No Rights history available







